AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 36.62 |
Market Cap | 3.99B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 2.64 |
PE Ratio (ttm) | 34.64 |
Forward PE | n/a |
Analyst | Buy |
Ask | 145.56 |
Volume | 139,173 |
Avg. Volume (20D) | 286,544 |
Open | 90.35 |
Previous Close | 89.82 |
Day's Range | 90.11 - 91.79 |
52-Week Range | 79.03 - 115.91 |
Beta | undefined |
About BCO
The Brink's Company provides secure transportation, cash management, and other security-related services in North America, Latin America, Europe, and internationally. The company offers armored vehicle transportation of valuables; automated teller machine (ATM) management services, such as cash replenishment, replenishment forecasting, cash optimization, ATM remote monitoring, service call dispatching, transaction processing, installation, and fi...
Analyst Forecast
According to 3 analyst ratings, the average rating for BCO stock is "Buy." The 12-month stock price forecast is $120.5, which is an increase of 31.75% from the latest price.
Next Earnings Release
Analysts project revenue of $1.26B, reflecting a 1.12% YoY growth and earnings per share of 1.86, making a -32.61% decrease YoY.
1 month ago · https://www.proactiveinvestors.com
Cyprium Metals moves towards restarting Nifty Project as a large-scale open-pit copper operationBoeing Co (NYSE:BA, ETR:BCO) has landed an order worth US$2.38 billion for aerial refuelers from the US Air Force. A contract to build a further 15 KC-46A Pegasus tankers was unveiled on Thursday, add...
1 month ago · https://www.proactiveinvestors.com
Hemogenyx Pharmaceuticals gets greenlight for clinical trialHemogenyx Pharmaceuticals PLC (LSE:HEMO, OTC:HOPHF) shares drove higher in Friday morning’s dealing, rising over 10% at one point, after it received Institutional Review Board (IRB) approval to begin ...
1 month ago · https://www.proactiveinvestors.com
Gap stock jumps in out-of-hours trade as earnings beat expectationsGap Inc (NYSE:GPS) shares popped some 15% higher overnight after it released better-than-expected financials after Thursday’s closing bell. Chief executive Richard Dickson said that Gap’s “brand reinv...
2 months ago · seekingalpha.com
The Brink's Company: Still Attractive, Even After The Easy Money Has Been MadeThe Brink's Company has had some mixed results but, on the whole, the company is doing just fine right now. It does have some growth aspects to it, plus shares are trading at really attractive levels ...